Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Cancer Res. 2009 Jul 1;69(13):5289-91. doi: 10.1158/0008-5472.CAN-09-0944. Epub 2009 Jun 23.

    Aneuploidy: cancer's fatal flaw?

    Source

    David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

    Abstract

    Aneuploidy is a characteristic of cancer, with greater than 90% of all solid tumors in humans carrying an aberrant karyotype. Yet, whether or how this condition contributes to tumorigenesis is not understood. Here we summarize our recent findings on the effects of aneuploidy on cell physiology and proliferation. These studies suggest that aneuploidy puts significant stress on the cell, which responds to this condition in what can be viewed as an aneuploidy stress response. We will discuss how our results may bear on our understanding of the role of this condition in tumorigenesis and how they may provide new opportunities for treatment of the disease.

    PMID:
    19549887
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2917070
    Free PMC Article

    Images from this publication.See all images (1)Free text

    Figure 1

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Recent activity

      • Aneuploidy: cancer's fatal flaw?
        Aneuploidy: cancer's fatal flaw?
        Cancer Res. 2009 Jul 1 ;69(13):5289-91. doi: 10.1158/0008-5472.CAN-09-0944. Epub 2009 Jun 23 .
        PubMed

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk